Invention Grant
US08741915B2 Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors
失效
二氢嘧啶-2（1H） - 酮化合物，为S-亚硝基谷胱甘肽还原酶抑制剂
- Patent Title: Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors
- Patent Title (中): 二氢嘧啶-2（1H） - 酮化合物，为S-亚硝基谷胱甘肽还原酶抑制剂
-
Application No.: US13496799Application Date: 2010-09-24
-
Publication No.: US08741915B2Publication Date: 2014-06-03
- Inventor: Xicheng Sun , Jian Qiu
- Applicant: Xicheng Sun , Jian Qiu
- Applicant Address: US CO Boulder
- Assignee: N30 Pharmaceuticals, Inc.
- Current Assignee: N30 Pharmaceuticals, Inc.
- Current Assignee Address: US CO Boulder
- Agency: Swanson & Bratschun, L.L.C.
- International Application: PCT/US2010/050164 WO 20100924
- International Announcement: WO2011/038204 WO 20110331
- Main IPC: A01N43/54
- IPC: A01N43/54 ; A61K31/505 ; A61K31/513 ; A61K31/506 ; C07D239/34 ; C07D239/38 ; C07D239/32
Abstract:
The present invention is directed to novel dihydropyrimidin-2(1H)-one compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.
Public/Granted literature
- US20120208817A1 Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors Public/Granted day:2012-08-16
Information query
IPC分类:
